Characteristic of herd immunity among the population of Stavropol region amid the COVID-19 epidemic

Author:

Popova A. Yu.1,Ezhlova E. B.1,Melnikova A. A.1,Smirnov V. S.2,Lyalina L. V.2,Ermakov A. V.3,Solomashchenko N. I.4,Kovalchuk I. V.3,Vasilenko E. A.4,Romanenko E. N.4,Zvoliborskaya A. V.4,Ryabykh A. V.4,Dmitrienko L. I.5,Mezhlumyan N. A.4,Sharova A. A.2,Vetrov V. V.2,Totolian A. A.2

Affiliation:

1. Federal Service for Supervision of Consumer Rights Protection and Human Wellbeing

2. Saint-Petersburg Research Institute of Epidemiology and Microbiology named after Pasteur

3. Federal Service for Supervision of Consumer Rights Protection and Human Wellbeing, Department in the Stavropol Territory

4. Center for Hygiene and Epidemiology in the Stavropol Territory

5. Ministry of Health of the Stavropol Territory

Abstract

Introduction. The first pandemic in the 21st century, caused by the pathogenic representative of the coronavirus SARS-CoV-2, began in the Chinese city of Wuhan, where the first outbreak of coronavirus pneumonia was recorded in December 2019. The disease spread so quickly around the world that already on February 11, 2020, WHO was forced to declare a pandemic of the “coronavirus disease 2019” COVID-19. The first case of COVID-19 in the Stavropol Territory was registered on March 20, 2020, and three weeks later, starting from the 15th week of the year, a steady increase in the incidence began, which lasted until the 52nd week. During the study period, the incidence increased from 21.1 to 28.3 per hundred thousand of the population. Growth 1.3 times.Purpose: to determine the dynamics of population immunity among the population of the Stavropol Territory in 2020-2021. during the period of an epidemic increase in the incidence of COVID-19. Materials and methods. The SARS-CoV-2 study was carried out according to a unified methodology within the framework of the program for assessing the population immunity of the population of the Russian Federation, developed by Rospotrebnadzor with the participation of the St. Pasteur. In total, 2688 people were examined, divided into 7 age groups. In the examined individuals, the level of specific IgG to the SARS-CoV-2 nucleocapsid was determined by the enzyme immunoassay.Results. The level of seroprevalence among residents of the Stavropol Territory was 9.8%. The largest proportion of seropositive individuals was found in the age groups 1-6 and 7-13 years old (19.2% and 19.7%, respectively). Seroprevalence had no gender differences and ranged from 9.3% to 10.8%. When assessing the distribution of the proportion of seropositive persons in different geographic territories of the region, it was found that the maximum proportion was found in the Kochubeevsky district (23.1%), the minimum in Kislovodsk (7.7%). Among convalescents, the content of specific antibodies to SARS-CoV-2 was noted in 73.3%, which is 7.8 times higher than the average population level. When conducting seromonitoring in the 2nd half of 2020, a 10-fold increase in seroprevalence was recorded, accompanied by a decrease in incidence from the 5th week of 2021. Among asymptomatic volunteers in whom SARS-CoV-2 RNA was detected by the polymerase chain reaction, antibody titers to viruses were found in 78.6%, which corresponds to the seroprevalence of convalescents. The proportion of seropositive persons among those who have come into contact with COVID-19 patients was 16.4%, (1.8 times higher than the average for the population). Out of 262 seroprevalent volunteers, the asymptomatic form of SARS-CoV-2 was detected in 92% of the examined, which indicates a significant role of the number of asymptomatic forms of infection in the epidemic process of COVID-19.Conclusion. The results of assessing the population immunity of the population of the Stavropol Territory indicate that it has not yet reached the threshold level at which a decrease in the intensity of the COVID-19 epidemic process can be expected. 

Publisher

SPRIDA

Subject

Infectious Diseases

Reference27 articles.

1. Smirnov V.S., Zarubaev V.V., Petlenko S.V. Biology of pathogens and control of influenza and ARVI. Saint Petersburg: Hippocrates, 2019, 334 p. (In Russian).

2. Ng L.F.P. The Virus That Changed My World PLoS Biol. 2003; 1 (3): e66. doi: 10.1371/journal.pbio.0000066.

3. Memish Z. A., Perlman S., Van Kerkhove M. D., Zumla A. Middle East respiratory syndrome Lancet. 2020;395(10229): 1063-1077. doi: 10.1016/S0140-6736 (19) 33221-0.

4. Lu H., C. Stratton W., Tang Y.-W. The Wuhan SARSCoV-2 — What’s next for China. J. Med. Virol. 2020;92(6):546- 54710.1002 / jmv.25738. doi: 10.1002/jmv.25738.

5. WHO Director-General’s remarks at the media briefing on 2019-nCoV on 11 February 2020. (Cited 15 Sep 2020) [Internet]. Available from: https://www.who.int/dg/speeches/ detail/who-director-general-s-remarks-at-the-media-briefingon-2019-ncov-on-11- february-2020 ...

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3